Effects of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines

Xi Zhang, Xue Han, Baolan Chen, Xi Fu, Yajie Gong, Wenhan Yang, Qingsong Chen
doi: https://doi.org/10.1101/2023.07.16.23292747

Abstract

Background Because of the significantly higher demand for nutrients during pregnancy, pregnant women are more likely to have nutrient deficiencies, which may adversely affect maternal and fetal health. The effect of nutritional supplements on the immune effects of inactivated SARS-CoV-2 vaccines during pregnancy is not clear.

Methods In a multicenter cross-sectional study, we enrolled 873 pregnant women aged 18-45 y in Guangdong, China. The general demographic characteristics of pregnant women and their use of nutritional supplements were investigated, and the serum antibody levels induced by inactivated SARS-CoV-2 vaccines were measured. A logistic regression model was used to analyze the association between nutritional supplements and SARS-CoV-2 antibody levels.

Results Of the 873 pregnant women enrolled, 825 (94.5%) took folic acid during pregnancy, 165 (18.9%) took iron supplements, and 197 (22.6%) took DHA. All pregnant women received at least one dose of inactivated SARS-CoV-2 vaccine, and the positive rates of serum SARS-CoV-2 neutralizing antibodies (NAbs) and immunoglobulin G (IgG) antibodies were 44.7% and 46.4%, respectively. After adjustment for confounding factors, whether pregnant women took folic acid, iron supplements, or DHA did not influence NAb positivity or IgG positivity (P > 0.05).Compared with pregnant women who did not take folic acid, the odds ratios (ORs) for the presence of SARS-CoV-2 NAb and IgG antibody in pregnant women who took folic acid were 0.69 (P = 0.282; 95% CI, 0.35-1.35) and 1.31 (P = 0.456; 95% CI, 0.64-2.67), respectively. Compared with pregnant women who did not take iron supplements, the ORs for the presence of NAb and IgG antibody in pregnant women who took iron supplements were 1.22 (P = 0.336; 95% CI, 0.81-1.84) and 1.01 (P = 0.956; 95% CI, 0.66-1.54), respectively. Similarly, the ORs for NAb and IgG antibody were 0.74 (P = 0.125; 95% CI, 0.51-1.08) and 0.97 (P = 0.881; 95% CI, 0.66-1.44) in pregnant women who took DHA compared with those who did not.

Conclusions Nutritional supplementation with folic acid, iron, or DHA during pregnancy was not associated with antibody levels in pregnant women who received inactivated SARS-CoV-2 vaccines.

1 Introduction

Since the outbreak of COVID-19, research and development of vaccines and various antiviral drugs to combat COVID-19 and its complications have increased worldwide1–4. At present, dozens of COVID-19 vaccines have been approved for use around the world. Because pregnant women have not been included in any clinical trials of COVID-19 vaccines5, 6, data on the efficacy and safety of these vaccines for pregnant women are limited. In addition, pregnant women have a significantly higher risk of COVID-19 infection, severe disease, and death due to changes in their immune response during pregnancy7–9. Therefore, it is necessary to understand the risks faced by pregnant women and the associated protective factors.

Adequate nutrition is essential to ensure the development, operation, and maintenance of the immune system, and nutritional supplements play an important role10–12. When malnutrition occurs, the immune response is affected, making the body susceptible to infection, which in turn exacerbates malnutrition. Excessive nutrient intake can adversely affect on all components of the immune system. Therefore, a well- balanced diet that includes plenty of nutrient-rich foods and supplements is necessary to prevent infectious diseases and ensure optimal immune function12, 13. Some studies have shown that nutrient supplements are particularly important during pregnancy. For example, folic acid is an indispensable nutrient during pregnancy, crucial in preventing neural tube defects14. In addition, folic acid supplementation during pregnancy has been found to reduce the risk of preeclampsia and preterm birth15.

Iron supplements are also necessary during pregnancy. Iron is an essential trace element for the human body. It supports hemoglobin synthesis and is used in the formation of iron-containing enzymes. It also constitutes the body’s iron storage in the form of ferritin16, 17. Iron deficiency anemia is one of the most common complications of pregnancy and a risk factor for excessive bleeding during childbirth, premature birth, and low birth weight18, 19. Pregnant women with iron deficiency anemia are more susceptible to SARS-CoV-2 infection.

DHA is an important component of brain cell membranes and is essential for fetal brain development. DHA supplementation during pregnancy promotes fetal brain development and plays an important role in increasing fetal intelligence and improving vision20, 21. The World Health Organization recommends that pregnant women should supplement with at least 300mg of DHA per day. Because of its immunomodulatory effects, DHA supplementation during pregnancy can also improve the immune health of the fetus.

Nutritional status during pregnancy is crucial. Many nutrients have potent immunomodulatory effects that can modify susceptibility to COVID-19 infection. It is worth exploring whether nutritional supplements can increase the immune response to COVID-19 vaccines. Therefore, the purpose of this study was to investigate the effect of dietary supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccine.

2 Materials and Methods

2.1 Study design and inclusion criteria

This multicenter study was performed in the obstetric clinics of three hospitals in Guangdong Province, China from December 2021 to July 2022. Inclusion criteria included (1) receiving at least one dose of inactivated vaccine before or during pregnancy, (2) being pregnant and having not been infected with COVID-19, and (3) agreeing to participate and providing informed consent. Pregnant women who were infected with COVID-19 after enrollment and were vaccinated with noninactivated COVID-19 vaccines were excluded. A total of 873 pregnant women met the inclusion criteria. The study was approved by the Medical Ethics Review Board of the School of Public Health, Guangdong Pharmaceutical University (IRB 2021-01), and complied with the Declaration of Helsinki guidelines. All participants signed paper informed consent form and minors were excluded from this study.

2.2 Study variable

We developed a survey questionnaire for pregnant women that included questions such as age (stratified by advanced maternal age as defined by the World Health Organization), body mass index(BMI), gravidity and parity, smoking, doses of vaccine taken, adverse events after vaccination, time since vaccination (defined as the time interval between the last dose of vaccine and blood collection), and other general demographic information, vaccination-related information, and information on the types of nutritional supplements used. Vaccination information was collected through the vaccination registration platform.

2.3 Sample collection and analysis

After enrollment, 5 mL of venous blood was collected, centrifuged to separate the serum, and stored in a –80°C freezer. Neutralizing antibody (NAb) levels were determined via a cytopathogenic effect assay. Specifically, serum samples were inactivated at 56°C for 30 min, diluted fourfold, and incubated with an equal volume (50 μL) of live SARS-CoV-2 virus suspension at 36.5°C in 5% CO2 for 2 h. Vero cells (1.0–2.0 × 105 cells/mL) were then added to the serum–virus suspension in the microplates and incubated in duplicate at 36.5°C in 5% CO2 for 5 d. Cytopathological effects were observed under the microscope. A NAb titer of <1:8 was considered negative and ≥1:8 was considered positive. SARS-CoV-2 immunoglobulin G (IgG) antibody was detected by chemiluminescence (Bioscience, Chongqing, China). An antibody level of <1.00 signal to cutoff ratio was considered negative, and a level of ≥1.00 was considered positive.

2.4 Statistical analysis

Statistical analysis was performed in IBM SPSS version 25 (SPSS Inc., IBM Corp., Armonk, NY). We analyzed demographic data, vaccination-related information, and antibody-positive rates of pregnant women according to whether they were taking nutritional supplements. Chi-squared and Fisher tests were used to compare proportions. Mann–Whitney U-test and Kruskal–Wallis test were used for nonnormal data. A logistic regression model was used to analyze the association between nutritional supplements and SARS-CoV-2 antibody positive rate. All P-values were two-sided, and differences with P-values <0.05 were considered statistically significant.

3 Results

3.1 Demographics of the study population

Of the 873 pregnant women included in the study, 825 (94.5%) took folic acid, 165 (18.9%) took iron supplements, and 197 (22.6%) took DHA during pregnancy. All pregnant women received at least one dose of inactivated SARS-CoV-2 vaccine, and the positive rates of serum SARS-CoV-2 NAbs and IgG antibodies were 44.7% and 46.4%, respectively. Of the women included in the study 87.9% were <35 years old. Basic demographic characteristics are presented in Tables 1 and 2.

View this table:
Table 1 Demographic characteristics of the participants stratified by type of nutrient supplements.
View this table:
Table 2 Vaccination and SARS-CoV-2 antibody positivity rates stratified by type of nutrient supplements.

We found significant differences in gravidity (P = 0.002), parity (P = 0.012), and education (P = 0.008) according to whether the pregnant women took folic acid. The percentage of pregnant women taking folic acid was higher in those with fewer than two pregnancies (80.6%), ≤ 1 birth (87.6%), and junior college education (34.7%). There were statistically significant differences in smoking (P = 0.008), weekly exercise frequency (P < 0.001), vaccine doses (P < 0.001), time since vaccination (P < 0.001), SARS-CoV-2 neutralizing antibody (P = 0.017), and IgG antibody (P < 0.001) according to whether participants were taking iron supplements. The presence or absence of DHA supplementation was similar to the presence or absence of iron supplementation. There were significant differences between groups in smoking (P = 0.017), weekly exercise frequency (P = 0.021), vaccine doses (P < 0.001), time since vaccination (P = 0.001), SARS-CoV-2 neutralizing antibody (P < 0.001), and IgG antibody (P = 0.012). There were no statistically significant differences in age, body mass index, per capita monthly income, or adverse events.

We further analyzed the general demographic characteristics of the pregnant women taking the three nutritional supplements separately. For pregnant women who took folic acid, the positive rate of SARS-CoV-2 neutralizing antibody varied significantly with vaccine doses (P < 0.001) and time since vaccination (P < 0.001). The positive rate of IgG antibody varied significantly with age (P = 0.025), adverse events (P = 0.027), vaccine doses (P < 0.001), and time since vaccination (P < 0.001). Among pregnant women who took iron, the positive rates of neutralizing antibody and IgG antibody varied significantly with vaccine doses (P < 0.001). In pregnant women taking DHA, the difference in the positive rate of IgG antibody between the groups varied significantly with gravidity (P = 0.040), vaccine doses (P < 0.001), and time since vaccination (P < 0.001).The positive rate of NAbs varied significantly with vaccine doses (P < 0.001) and time since vaccination (P = 0.009) (see Tables 3–5).

View this table:
Table 3 Demographic characteristics of the participants taking folic acid.
View this table:
Table 4 Demographic characteristics of the participants taking iron supplements.
View this table:
Table 5 Demographic characteristics of the participants taking DHA.

3.2 Effects of nutritional supplements on antibody levels

To determine the effect of nutritional supplements on antibody levels, multivariate logistic regression analysis was performed. After adjustment for confounding factors such as age, education, vaccine doses, and time since vaccination, we found that there was no significant difference in the positive rates of SARS-CoV-2 neutralizing antibody and IgG antibody according to whether participants took the three nutritional supplements (P > 0.05). Compared with pregnant women who did not take folic acid, the odds ratios (ORs) for the presence of SARS-CoV-2 NAb and IgG antibody in pregnant women who took folic acid were 0.69 (P = 0.282; 95% CI, 0.35-1.35) and 1.31 (P = 0.456; 95% CI, 0.64-2.67), respectively. Compared with pregnant women who did not take iron supplements, the ORs for the presence of NAb and IgG antibody in pregnant women who took iron supplements were 1.22 (P = 0.336; 95% CI, 0.81- 1.84) and 1.01 (P = 0.956; 95% CI, 0.66-1.54), respectively. Similarly, the ORs for NAb and IgG antibody were 0.74 (P = 0.125; 95% CI, 0.51-1.08) and 0.97 (P = 0.881; 95% CI, 0.66-1.44) in pregnant women who took DHA compared with those who did not (Table 6).

View this table:
Table 6 Multivariable logistic regression analysis of Nutritional supplements and antibody positivity.

4 Discussion

The present study showed no association between supplementation during pregnancy and antibody levels in pregnant women who received inactivated SARS- CoV-2 vaccines.

During the COVID-19 pandemic, vaccination has proven to be the most effective control measure in establishing an immune barrier and reducing the rate of severe disease. Although pregnant women were not included in the clinical trials of COVID- 19 vaccines before market release, they face higher severity and mortality rates once infected. Therefore, there is a greater need for pregnant women to get vaccinated in order to protect themselves and their fetuses. With more attention paid to pregnant women’s health and nutrient intake, nutritional supplements have been ubiquitously used during pregnancy. Because the development and maintenance of immune cells that support vaccine response depend on a sufficient supply of nutrients, the role of nutritional supplements in immune response to vaccines has drawn increasing attention. Clinical studies show that low plasma DHA levels during fetal development are associated with cognitive and behavioral disorders22. The brain needs DHA supplementation during development of the nervous system. DHA supplementation during pregnancy can increase fetal birth weight, reduce the risk of preterm birth and low birth weight, and also have a positive effect on infant attention regulation23, 24. Thus it is necessary to pay attention to DHA intake during pregnancy. In a double-blind, placebo-controlled, randomized trial, children of mothers who took DHA supplements during pregnancy were found to have better problem-solving abilities at age 9 y than those who did not25. Taking DHA supplements also improves the health of pregnant women. A randomized controlled trial of low-income African American women showed that pregnant women who received DHA supplementation reported lower levels of stress and had lower levels of stress hormones26. The results of this research indicate that DHA intake is not associated with pregnant women’s antibody levels.

Folic acid is essential for DNA and protein synthesis and also plays a crucial role in adaptive immune responses27. Pregnancy is a common cause of folic acid deficiency, which can lead to pregnancy complications and affect the growth and development of children, including pregnancy-induced hypertension, increased risk of miscarriage, neural tube defects, cleft lip and palate. Studies have shown that folic acid supplementation during pregnancy may help reduce the risk of prenatal depression and have beneficial effects on fertility28, 29. The Centers for Disease Control and Prevention in the USA recommends that women of childbearing age supplement with 400 μg/d of folic acid daily, beginning at least four weeks before conception and continuing through the first three months of pregnancy. In terms of vaccine immune response, taking folic acid during pregnancy increases the persistence of hepatitis B surface antibodies in the fetus30. Our study showed that taking folic acid is not associated with pregnant women’s antibody levels. This is because the aforementioned study explored the relationship between folic acid supplements during pregnancy and the immune persistence of antibodies in the fetus, which differs from the focus of our research. Other confounding factors in this study, such as vaccine dosage and income level, may also contribute to this result. In a cluster randomized clinical trial conducted in Niger, the effect of prenatal nutritional supplements on immune responses to oral attenuated rotavirus vaccine was assessed. The results showed that in this low-income country, the types of prenatal nutritional supplements have no effect on immune reactions31.

Iron, an essential nutrient, plays a significant role in the immune system32 . Every cell and organ system in the human body requires iron for normal development and metabolic function. Iron deficiency often causes anemia during pregnancy, severely threatening the health of pregnant women and fetuses and increasing the incidence of adverse pregnancy outcomes. A meta-analysis showed a dose-response relationship between iron and birth weight, where before reaching a dose of 66mg, every additional 10mg/day of iron supplementation can increase birth weight by 15.1g, reduce the risk of low birth weight by 3%, and decrease the rate of anemia by 12%33. In a birth cohort study, anemia and iron deficiency during babies’ vaccination were found to predict a decrease in response to vaccines against diphtheria, whooping cough, and pneumococcus. Iron supplementation increases antibody affinity and seroconversion of the measles vaccine34. Our study showed that taking iron supplements does not affect antibody levels in pregnant women. This may be because the efficacies of various vaccines differ across populations, age groups, and environmental conditions.

Iron, folic acid and DHA are important nutrient supplements during pregnancy. A cross-sectional study conducted in China found that the use rate of folic acid was the highest (81.7%) and the most stable among various nutrient supplements35. Women of childbearing age and pregnant women are at risk of developing anemia, and iron deficiency is the most recognized risk factor for this condition. Pregnancy poses a significant risk of iron deficiency for women. Iron requirements are greatly increased compared to the non-pregnant state. Adequate iron during pregnancy leads to better pregnancy outcomes for both mother and child. During pregnancy, DHA is transferred in large quantities to the fetus through the placenta. The maternal DHA nutritional status directly affects the fetal DHA nutritional status, which in turn affects fetal development.

This research is a cross-sectional study based on real-world data, differing from the aforementioned studies in terms of research design. Furthermore, differences in research subjects and vaccines can also cause different results. For example, the mechanisms of vaccines may vary between the immune systems of fetuses and pregnant women, thereby producing inconsistent immune responses. Finally, readjusting an established immune system may require additional intervention beyond nutritional supplements, and the most effective supplement has not been identified.

We acknowledge some limitations in present study. Because the data on supplements taken by pregnant women were based on self-report, there may have been some recall bias. Another drawback is the lack of survey information on nutrient intake among pregnant women, which could lead to imprecise results. In the future, we may consider measuring the baseline levels of nutritional supplements in the first trimester and evaluating the effects of nutrient supplements such as vitamin D, calcium, and zinc on the immune levels of pregnant women, to provide more effective recommendations on nutrient intake for pregnant women.

5 Conclusions

Nutritional supplementation with folic acid, iron, and DHA during pregnancy was not associated with antibody levels in pregnant women who received inactivated SARS-CoV-2 vaccines.

Data Availability

De-identified data in Chinese collected for the study (with data dictionary) might be made available upon approval by the study investigators, with relevant agreements (eg, data sharing agreement) and approvals (eg, relevant ethics approvals). Requests should be directed to the corresponding author in the first instance.

Acknowledgments

We thank all pregnant women who took part in this survey and the health care workers who helped us.

References

  1. [1].↵
    Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. (2020) May 14;55(5):2000547. doi: 10.1183/13993003.00547-2020.
    OpenUrlAbstract/FREE Full Text
  2. [2].
    Skirrow H, Barnett S, Bell S, Riaposova L, Mounier-Jack S, Kampmann B, et al. Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK. BMC Pregnancy Childbirth. (2022) Jan 14;22(1):33. doi: 10.1186/s12884-021-04321-3.
    OpenUrlCrossRefPubMed
  3. [3].
    Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence. J Am Acad Dermatol.(2021)Nov;85(5):1274–1284.doi: 10.1016/j.jaad.2021.07.054.
    OpenUrlCrossRef
  4. [4].↵
    Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID- 19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. (2021) Oct;21(10):626–636. doi: 10.1038/s41577-021-00592-1.
    OpenUrlCrossRefPubMed
  5. [5].↵
    Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, et al. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. (2021) Dec;44(12):1247–1269. doi:10.1007/s40264-021-01131-6.
    OpenUrlCrossRef
  6. [6].↵
    Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. (2021) Feb 4;384(5):403–416. doi: 10.1056/NEJMoa2035389.
    OpenUrlCrossRefPubMed
  7. [7].↵
    Gorun F, Motoi S, Malita D, Navolan DB, Nemescu D, Olariu TR, et al. Cytomegalovirus seroprevalence in pregnant women in the western region of Romania: A large-scale study. Exp Ther Med. (2020) Sep;20(3):2439–2443. doi: 10.3892/etm.2020.8945.
    OpenUrlCrossRef
  8. [8].
    Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. (2021) Aug 1;175(8):817–826. doi: 10.1001/jamapediatrics.2021.1050. Erratum in: JAMA Pediatr. 2022 Jan 1;176(1):104.
    OpenUrlCrossRefPubMed
  9. [9].↵
    Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. (2021) Aug 24;326(8):728–735. doi: 10.1001/jama.2021.11035.
    OpenUrlCrossRefPubMed
  10. [10].↵
    Maggini S, Pierre A, Calder PC. Immune Function and Micronutrient Requirements Change over the Life Course. Nutrients. (2018) Oct 17;10(10):1531. doi: 10.3390/nu10101531.
    OpenUrlCrossRefPubMed
  11. [11].
    Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, et al. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients. (2020) Sep 29;12(10):2992. doi: 10.3390/nu12102992.
    OpenUrlCrossRef
  12. [12].↵
    Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, Bohn T. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients. (2020) May27;12(6):1562. doi: 10.3390/nu12061562.
    OpenUrlCrossRefPubMed
  13. [13].↵
    Samartin S., Chandra R. Obesity, overnutrition and the immune system. Nutr. Res. (2001);21:243–262. doi: 10.1016/S0271-5317(00)00255-4.
    OpenUrlCrossRef
  14. [14].↵
    Brown B, Wright C. Safety and efficacy of supplements in pregnancy. Nutr Rev. (2020) Oct 1;78(10):813–826. doi: 10.1093/nutrit/nuz101.
    OpenUrlCrossRefPubMed
  15. [15].↵
    Bulloch RE, Lovell AL, Jordan VMB, et al. Maternal folic acid supplementation for the prevention of preeclampsia: a systematic review and meta- analysis. Paediatr Perinat Epidemiol. (2018);32:346–357.
    OpenUrlPubMed
  16. [16].↵
    Zamora TG, Guiang SF 3rd, Widness JA, Georgieff MK. Iron is prioritized to red blood cells over the brain in phlebotomized anemic newborn lambs. Pediatr Res. (2016) Jun;79(6):922–8. doi: 10.1038/pr.2016.20.
    OpenUrlCrossRef
  17. [17].↵
    Petry N, Olofin I, Hurrell RF, Boy E, Wirth JP, Moursi M, et al. The Proportion of Anemia Associated with Iron Deficiency in Low, Medium, and High Human Development Index Countries: A Systematic Analysis of National Surveys. Nutrients. (2016) Nov 2;8(11):693. doi: 10.3390/nu8110693.
    OpenUrlCrossRefPubMed
  18. [18].↵
    Figueiredo ACMG, Gomes-Filho IS, Silva RB, Pereira PPS, Mata FAFD, Lyrio AO, et al. Maternal Anemia and Low Birth Weight: A Systematic Review and Meta-Analysis. Nutrients. (2018) May 12;10(5):601. doi: 10.3390/nu10050601.
    OpenUrlCrossRef
  19. [19].↵
    Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr. (2016) Feb;103(2):495–504. doi: 10.3945/ajcn.115.107896.
    OpenUrlAbstract/FREE Full Text
  20. [20].↵
    Shulkin M, Pimpin L, Bellinger D, Kranz S, Fawzi W, Duggan C, et al. n-3 Fatty Acid Supplementation in Mothers, Preterm Infants, and Term Infants and Childhood Psychomotor and Visual Development: A Systematic Review and Meta-Analysis. J Nutr. (2018) Mar 1;148(3):409–418. doi: 10.1093/jn/nxx031.
    OpenUrlCrossRefPubMed
  21. [21].↵
    Larqué E, Gil-Sánchez A, Prieto-Sánchez MT, Koletzko B. Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr. (2012) Jun;107 Suppl 2:S77–84. doi: 10.1017/S0007114512001481.
    OpenUrlCrossRefPubMed
  22. [22].↵
    Jouanne M, Oddoux S, Noël A, Voisin-Chiret AS. Nutrient Requirements during Pregnancy and Lactation. Nutrients. (2021) Feb 21;13(2):692. doi: 10.3390/nu13020692.
    OpenUrlCrossRefPubMed
  23. [23].↵
    Vinding RK, Stokholm J, Sevelsted A, Chawes BL, Bønnelykke K, Barman M, et al. Fish Oil Supplementation in Pregnancy Increases Gestational Age, Size for Gestational Age, and Birth Weight in Infants: A Randomized Controlled Trial. J Nutr. (2019) Apr 1;149(4):628–634. doi: 10.1093/jn/nxy204.
    OpenUrlCrossRef
  24. [24].↵
    Colombo J, Gustafson KM, Gajewski BJ, Shaddy DJ, Kerling EH, Thodosoff JM, et al. Prenatal DHA supplementation and infant attention. Pediatr Res. (2016) Nov;80(5):656–662. doi: 10.1038/pr.2016.134.
    OpenUrlCrossRef
  25. [25].↵
    Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr. (2007) Jun;85(6):1572–7. doi: 10.1093/ajcn/85.6.1572.
    OpenUrlAbstract/FREE Full Text
  26. [26].↵
    Keenan K, Hipwell AE, Bortner J, Hoffmann A, McAloon R. Association between fatty acid supplementation and prenatal stress in African Americans: a randomized controlled trial. Obstet Gynecol. (2014) Dec;124(6):1080–1087. doi: 10.1097/AOG.0000000000000559.
    OpenUrlCrossRefPubMed
  27. [27].↵
    Kumar P, Kumar M, Bedi O, Gupta M, Kumar S, Jaiswal G, et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology. (2021) Aug;29(4):1001–1016. doi: 10.1007/s10787-021-00826-7.
    OpenUrlCrossRef
  28. [28].↵
    Jin X, Cheng Z, Yu X, Tao Q, Huang R, Wang S. Continuous supplementation of folic acid in pregnancy and the risk of perinatal depression-A meta-analysis. J Affect Disord. (2022) Apr 1;302:258–272. doi: 10.1016/j.jad.2022.01.
    OpenUrlCrossRef
  29. [29].↵
    Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol. (2018) Apr;218(4):379–389. doi: 10.1016/j.ajog.2017.08.010.
    OpenUrlCrossRef
  30. [30].↵
    Zhao X, Pang X, Wang F, Cui F, Wang L, Zhang W. Maternal folic acid supplementation and antibody persistence 5 years after hepatitis B vaccination among infants. Hum Vaccin Immunother. (2018);14(10):2478–2484. doi: 10.1080/21645515.2018.1482168.
    OpenUrlCrossRef
  31. [31].↵
    Sanaka S, Garba S, Plikaytis B, Malone McNeal M, Guindo O, Langendorf C, et al. Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial. PLoS Med. (2021) Aug 10;18(8):e1003720. doi: 10.1371/journal.pmed.
    OpenUrlCrossRef
  32. [32].↵
    Kehl-Fie TE, Skaar EP. Nutritional immunity beyond iron: a role for manganese and zinc. Curr Opin Chem Biol. (2010) Apr;14(2):218–24. doi: 10.1016/j.cbpa.2009.11.008.
    OpenUrlCrossRefPubMedWeb of Science
  33. [33].↵
    Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. (2013) Jun 21;346:f3443. doi: 10.1136/bmj.f3443.
    OpenUrlAbstract/FREE Full Text
  34. [34].↵
    Toffel NU, Uyoga MA, Mutuku FM, Frost JN, Mwasi E, Paganini D, et al. Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants. Front Immunol. (2020) Jul 13;11:1313. doi: 10.3389/fimmu.2020.01313.
    OpenUrlCrossRef
  35. [35].↵
    Chatterjee R, Shand A, Nassar N, Walls M, Khambalia AZ. Iron supplement use in pregnancy - Are the right women taking the right amount? Clin Nutr. (2016) Jun;35(3):741–7. doi: 10.1016/j.clnu.2015.05.014.
    OpenUrlCrossRef
Back to top
Posted July 18, 2023.
Download PDF
Data/Code
Email
Effects of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines
Xi Zhang, Xue Han, Baolan Chen, Xi Fu, Yajie Gong, Wenhan Yang, Qingsong Chen
medRxiv 2023.07.16.23292747; doi: https://doi.org/10.1101/2023.07.16.23292747
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area